Interest in CBD Products Keeps Soaring, but Health Experts Wary

(HealthDay News, October 23) Interest in cannabidiol (CBD), one of the chemical compounds in marijuana, has skyrocketed in recent years.

Fans of CBD claim it can address a wide variety conditions. And products containing CBD – from gummies to droplets – appear to be everywhere.

However, the Food and Drug Administration has only approved one CBD-containing product – Epidiolex (to treat epilepsy symptoms).

 "At this time there are no known benefits for taking CBD over-the-counter,” Dr. Davey Smith, a physician and chief of Infectious Diseases and Global Public Health at University of California San Diego said in a news release. “Moreover, some consumers might forgo seeing a physician or taking medications with known, tested and approved therapeutic benefits in favor of CBD and thereby become sicker or succumb to their illness.” Read more.